A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice

Clinical and Experimental Immunology

Volumn 177, Issue 2, 2014, Pages 391-403

  Adlercreutz, E H ^a   Weile, C ^b   Larsen, J ^b   Engkilde, K ^b   Agardh, D ^a   Buschard, K ^b   Antvorskov, J C ^b  

^a LUND UNIVERSITY   (Sweden)

^b Rigshospitalet   (Denmark)

Author keywords

Coeliac disease; Gluten; Gluten free diet; NKG2D; Type 1 diabetes

Indexed keywords

CD71 ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; FLUORESCENCE ACTIVATED CELL SORTER; GLUTEN FREE DIET; INSULITIS; INTESTINE; LYMPH NODE; LYMPHOID TISSUE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

COELIAC DISEASE; GLUTEN; GLUTEN-FREE DIET; NKG2D; TYPE 1 DIABETES;

ANIMALS; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; DIET, GLUTEN-FREE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOPHENOTYPING; INTESTINES; ISLETS OF LANGERHANS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, TRANSFERRIN; RNA, MESSENGER;

EID: 84904012030     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12340     Document Type: Article

References (62)

1. Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23:464-483.
2. Hansen D, Brock-Jacobsen B, Lund E etal. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes Care 2006; 29:2452-2456.
3. Coleman DL, Kuzava JE, Leiter EH. Effect of diet on incidence of diabetes in nonobese diabetic mice. Diabetes 1990; 39:432-436.
4. Hoorfar J, Scott FW, Cloutier HE. Dietary plant materials and development of diabetes in the BB rat. J Nutr 1991; 121:908-916.
5. Scott FW. Food-induced type 1 diabetes in the BB rat. Diabetes Metab Rev 1996; 12:341-359.
6. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev 1999; 15:323-327.
7. Funda DP, Kaas A, Tlaskalova-Hogenova H, Buschard K. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Diabetes Metab Res Rev 2008; 24:59-63.
8. Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab 2003; 88:162-165.
9. Sildorf SM, Fredheim S, Svensson J, Buschard K. Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitus. BMJ Case Rep 2012; doi:10.1136/bcr.02.2012.5878.
10. Troncone R, Franzese A, Mazzarella G etal. Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am J Gastroenterol 2003; 98:590-595.
11. Auricchio R, Paparo F, Maglio M etal. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004; 53:1680-1683.
12. Mojibian M, Chakir H, Lefebvre DE etal. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009; 58:1789-1796.
13. Scott FW, Rowsell P, Wang GS, Burghardt K, Kolb H, Flohe S. Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 2002; 51:73-78.
14. Schmid S, Koczwara K, Schwinghammer S, Lampasona V, Ziegler AG, Bonifacio E. Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. Clin Immunol 2004; 111:108-118.
15. Norris JM, Barriga K, Klingensmith G etal. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003; 290:1713-1720.
16. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1721-1728.
17. Hansen AK, Ling F, Kaas A, Funda DP, Farlov H, Buschard K. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice. Diabetes Metab Res Rev 2006; 22:220-225.
18. Marietta EV, Gomez AM, Yeoman C etal. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLOS ONE 2013; 8:e78687.
19. Patrick C, Wang GS, Lefebvre DE etal. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes 2013; 62:2036-2047.
20. Hanninen A, Jaakkola I, Jalkanen S. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol 1998; 160:6018-6025.
21. Hanninen A, Salmi M, Simell O, Jalkanen S. Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes 1996; 45:1173-1180.
22. Antvorskov JC, Fundova P, Buschard K, Funda DP. Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice. PLOS ONE 2012; 7:e33315.
23. Antvorskov JC, Fundova P, Buschard K, Funda DP. Dietary gluten alters the balance of pro-inflammatory and anti-inflammatory cytokines in T cells of BALB/c mice. Immunology 2013; 138:23-33.
24. Guy-Grand D, Cuenod-Jabri B, Malassis-Seris M, Selz F, Vassalli P. Complexity of the mouse gut T cell immune system: identification of two distinct natural killer T cell intraepithelial lineages. Eur J Immunol 1996; 26:2248-2256.
25. Abadie V, Discepolo V, Jabri B. Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol 2012; 34:551-566.
26. Ogasawara K, Hamerman JA, Ehrlich LR etal. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20:757-767.
27. Van Belle TL, Ling E, Haase C, Bresson D, Urso B, von Herrath MG. NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes. J Autoimmun 2013; 40:66-73.
28. Qin H, Lee IF, Panagiotopoulos C etal. Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Diabetes 2011; 60:857-866.
29. Rodacki M, Svoren B, Butty V etal. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007; 56:177-185.
30. Roberts AI, Lee L, Schwarz E etal. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 2001; 167:5527-5530.
31. Meresse B, Chen Z, Ciszewski C etal. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21:357-366.
32. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994; 91:6259-6263.
33. Stephens HA. MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol 2001; 22:378-385.
34. Kasahara M, Watanabe Y, Sumasu M, Nagata T. A family of MHC class I-like genes located in the vicinity of the mouse leukocyte receptor complex. Proc Natl Acad Sci USA 2002; 99:13687-13692.
35. Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 2002; 169:4079-4083.
36. Malarkannan S, Shih PP, Eden PA etal. The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol 1998; 161:3501-3509.
37. Zou Z, Nomura M, Takihara Y, Yasunaga T, Shimada K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J Biochem 1996; 119:319-328.
38. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1:41-49.
39. Elliott RB, Reddy SN, Bibby NJ, Kida K. Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia 1988; 31:62-64.
40. Aaen K, Rygaard J, Josefsen K etal. Dependence of antigen expression on functional state of beta-cells. Diabetes 1990; 39:697-701.
41. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-386.
42. Arase H, Saito T, Phillips JH, Lanier LL. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 2001; 167:1141-1144.
43. Pellicci DG, Hammond KJ, Coquet J etal. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J Immunol 2005; 175:4416-4425.
44. Werner JM, Busl E, Farkas SA, Schlitt HJ, Geissler EK, Hornung M. DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice. BMC Immunol 2011; 12:26.
45. Franco A, Paroli M, Testa U etal. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J Exp Med 1992; 175:1195-1205.
46. Judd W, Poodry CA, Strominger JL. Novel surface antigen expressed on dividing cells but absent from nondividing cells. J Exp Med 1980; 152:1430-1435.
47. Shipkova M, Wieland E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta 2012; 413:1338-1349.
48. Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 1981; 78:3039-3043.
49. Resendiz-Albor AA, Esquivel R, Lopez-Revilla R, Verdin L, Moreno-Fierros L. Striking phenotypic and functional differences in lamina propria lymphocytes from the large and small intestine of mice. Life Sci 2005; 76:2783-2803.
50. Ghazarian L, Simoni Y, Pingris K, Beaudoin L, Lehuen A. [Regulatory role of NKT cells in the prevention of type 1 diabetes]. Med Sci (Paris) 2013; 29:722-728.
51. Calleja S, Vivas S, Santiuste M etal. Dynamics of non-conventional intraepithelial lymphocytes-NK, NKT, and gammadelta T in celiac disease: relationship with age, diet, and histopathology. Dig Dis Sci 2011; 56:2042-2049.
52. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000; 18:53-81.
53. Halstensen TS, Brandtzaeg P. TCR gamma/delta + and CD8+TCR alpha/beta + intraepithelial lymphocytes (IEL) express proliferation marker (Ki-67) in the coeliac lesion. Adv Exp Med Biol 1995; 371B:1333-1338.
54. Gravano DM, Hoyer KK. Promotion and prevention of autoimmune disease by CD8+ T cells. J Autoimmun 2013; 45:68-79.
55. Roep BO. Islet autoreactive CD8 T-cells in type 1 diabetes: licensed to kill? Diabetes 2008; 57:1156-1157.
56. Hue S, Mention JJ, Monteiro RC etal. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004; 21:367-377.
57. Ogasawara K, Hamerman JA, Hsin H etal. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003; 18:41-51.
58. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235:267-285.
59. Cheney EE, Wise EL, Bui JD etal. A dual function of NKG2D ligands in NK-cell activation. Eur J Immunol 2012; 42:2452-2458.
60. Maier LM, Howlett SK, Rainbow KM etal. NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice. J Immunol 2008; 181:7073-7080.
61. Buschard K. What causes type 1 diabetes? Lessons from animal models. APMIS Suppl 2011; 132:1-19.
62. Catassi C, Bai JC, Bonaz B etal. Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013; 5:3839-3853.